Australia, Feb. 18 -- Tyra Biosciences Inc., owns the trademark (2527919) for 'TYRA BIOSCIENCES' till Oct. 25, 2034.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceuticals for the treatment of rare genetic diseases; pharmaceuticals for the treatment of musculo-skeletal disorders; pharmaceuticals for the treatment of skeletal dysplasia; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of cells that are resistant to drugs; pharmaceuticals for the treatment and prevention of drug resistance; anti-cancer pharmaceuticals.] and 44 [Providing medical information; providing medical information in the field of rare diseases, musculo-skeletal disorders, and skeletal dysplasia; providing medical information via a website; providing information in the field of rare diseases, musculo-skeletal disorders, and skeletal dysplasia via a website; providing information in the field of the diagnosis and treatment of cancer via a website; providing medical information in the field of oncology; providing information in the field of the diagnosis and treatment of cancer via a website.]
Type of Mark: Word
Date of Acceptance: Dec. 10, 2025
Registration Advertised: Feb. 17
For further details contact Spruson & Ferguson and Kevin M. Bovard Baker & Hostetler LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2527919.
Disclaimer: Curated by HT Syndication.
